Abstract
We have discovered high-affinity antagonists (exemplified by 11 and 12) that are the most selective for alpha(1d)-adrenergic receptors (alpha(1d)-AR) reported to date. In cloned receptor assay systems, 12 displays at least 95-fold selectivity for the alpha(1d)-AR over all other G-protein-coupled receptors tested, and the subtype selectivity of 11 was confirmed in pharmacologically defined isolated tissue preparations.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adrenergic alpha-1 Receptor Antagonists*
-
Animals
-
Aorta, Thoracic / drug effects
-
Aorta, Thoracic / physiology
-
Humans
-
In Vitro Techniques
-
Male
-
Muscle Contraction / drug effects
-
Muscle, Smooth / drug effects
-
Muscle, Smooth / physiology
-
Piperazines / chemical synthesis*
-
Piperazines / chemistry
-
Piperazines / pharmacology
-
Radioligand Assay
-
Rats
-
Receptors, Adrenergic, alpha-1 / physiology
-
Spiro Compounds / chemical synthesis*
-
Spiro Compounds / chemistry
-
Spiro Compounds / pharmacology
-
Spleen / drug effects
-
Spleen / physiology
-
Stereoisomerism
-
Structure-Activity Relationship
-
Vas Deferens / drug effects
-
Vas Deferens / physiology
Substances
-
8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)-1-methylethyl)-8-azaspiro(4.5)decane-7,9-dione
-
8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)ethyl)-8-azaspiro(4.5)decane-7,9-dione
-
ADRA1D protein, human
-
Adrenergic alpha-1 Receptor Antagonists
-
Piperazines
-
Receptors, Adrenergic, alpha-1
-
Spiro Compounds